The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / How Gout Patients Can Stay on Target with the Go for Six Campaign

How Gout Patients Can Stay on Target with the Go for Six Campaign

May 12, 2017 • By Karen Appold

  • Tweet
  • Email
Print-Friendly Version / Save PDF

With guidelines from the ACR and the European League Against Rheumatism (EULAR) recommending gout patients keep their uric acid levels below 6.0 mg/dL, the Gout & Uric Acid Education Society (GUAES) is emphasizing 6 as a target for patients, says N. Lawrence Edwards, MD, MACP, MACR, chair and CEO of GUAES. Dubbed the Go for Six campaign, the society kicked off the education initiative on May 22, 2015, with Gout Awareness Day.1,2

You Might Also Like
  • The ACR’s Gout Guideline Co-Author Shares Insight on Treating Pain, Ongoing Patient Care
  • Patient Fact Sheet – Gout
  • Bariatric Surgery May Help Obese Patients with Gout, Diabetes
Also By This Author
  • Hospital for Special Surgery Focuses on Measuring, Adding Value

Dr. Edwards, who co-authored the ACR’s most current guideline, 2012 Guidelines for the Management of Gout, and is a professor of medicine in and vice chair of the Department of Medicine, University of Florida, Gainesville, Fla., says both organizations support a treat-to-target approach and chose 6.0 mg/dL as the target number because multiple clinical trials demonstrated that when a gout patient suppresses their uric acid level to 6.0 mg/dL or below, their main symptoms may decrease in frequency over the first couple of years of treatment with first-line medications until they completely disappear. And if tophi exist, they may also disappear in time. By comparison, when a patient’s uric acid levels remain above 7.0, their disease continues to worsen over time.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Embrace Treatment
So how do physicians advise patients on how to keep their uric acid levels below 6.0?

Some patients think they can treat gout with diet alone, but Dr. Edwards says that is rarely the case. Although he does recommend a Mediterranean diet, with its emphasis on fresh fruits and fish, Dr. Edwards says, “if [patients] know that certain foods trigger their gout flares, such as red meat, shellfish or beer, then they should avoid them. But doing that alone won’t eliminate gout symptoms.”

N. Lawrence Edwards, MD, MACP, MACR

Dr. Edwards says patients can become compliant by taking a daily uric acid-lowering therapy, primarily allopurinol or febuxostat. In addition, patients should have their uric acid levels checked every one to two months as they adjust to the medication. After a patient’s uric acid level dips below 6.0, they can have their levels checked less frequently—every six to 12 months—to ensure it remains in range.

Throughout a patient’s lifetime, it’s important to check uric acid levels because alterations in an individual’s environment and body can cause uric acid levels to creep upward. For example, certain medications that treat comorbid conditions of gout—such as diuretics for hypertension, low-dose aspirin for coronary artery disease and lipid-lowering agents for high cholesterol—can increase uric acid levels. If a patient loses a significant amount of weight, they may be able to decrease their dosage of a uric acid-lowering therapy.

Pages: 1 2 | Single Page

Filed Under: Conditions, Crystal Arthritis Tagged With: Go for Six campaign, Gout, Gout & Uric Acid Education Society (GUAES), guideline, patient education

You Might Also Like:
  • The ACR’s Gout Guideline Co-Author Shares Insight on Treating Pain, Ongoing Patient Care
  • Patient Fact Sheet – Gout
  • Bariatric Surgery May Help Obese Patients with Gout, Diabetes
  • The ACR’s & EULAR’s Gout Guidelines Include Treatment Approaches

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)